Rotavirus: Pillars of Care -- A Comprehensive Overview of Rotavirus: Understanding Virology and Epidemiology to Effectively Manage and Prevent Disease CME

Penelope H. Dennehy, MD; Gary S. Marshall, MD; Mary Allen Staat, MD, MPH Author Information and Disclosures

Release Date: April 8, 2008; Valid for credit through April 8, 2009

Credits Available
Physicians - maximum of 2.0 AMA PRA Category 1 Credit(s)™ for physicians

This CME program, Pillars of Care, was developed by the faculty for use on Medscape.

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the educational content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 Med Learning Group.
Merck
Learning Objectives
Upon completion of this activity, participants should be able to:
  • Identify the major health concern for children infected with rotavirus
  • Describe the standard treatment for rotavirus in the developed world
  • Name three ways the rotavirus disease burden negatively affects the economy
  • Identify the ages at which children should receive the new rotavirus vaccines, specific for each vaccine.
Author Disclosures
Penelope H. Dennehy,
Disclosure: Contracted Research: Merck & Co., Inc and GlaxoSmithKline.

Gary S. Marshall, MD
Disclosure: Consulting Fees, Speaker's Bureau, and Contracted Research: GlaxoSmithKline; Merck & Co., Inc.; sanofi-aventis.

Mary Allen Staat, MD, MPH
Disclosure: Consulting Fees: GlaxoSmithKline and Merck & Co., Inc. Speakers Bureau: Merck & Co., Inc. Contracted Research: GlaxoSmithKline

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Jan Hixon, RN, MSN, Postgraduate Institute for Medicine: no real or apparent conflict of interest to report.

Tara Hun-Dorris, Medical Writer, Med Learning Group: consultant for UCB-Group, Inc.
 
Postgraduate Institute for Medicine
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Postgraduate Institute for Medicine and Med Learning Group. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Postgraduate Institute for Medicine designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.